D-0324-2026 Class II Ongoing

Recalled by F.H. INVESTMENTS, Inc. (Dba Asteria Health) — Birmingham, AL

FDA drug recall D-0324-2026 was initiated by F.H. INVESTMENTS, Inc. (Dba Asteria Health) on Jan 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 194,336 pellets.

Recall details

Product Type
Drugs
Report Date
Feb 18, 2026
Initiation Date
Jan 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
194,336 pellets

Product description

Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.

Reason for recall

Presence of Foreign substance - potential presence of metal particulate matter

Distribution pattern

Nationwide in the USA

Code information

Lot#: 251000127, Exp. 06/03/2026; 251000128, Exp. 06/05/2026; 251000133, 251000134, 251000135, Exp. 06/16/2026; 251000138, 251000139, 251000140, 251000141, Exp. 06/25/2026; 251000147, 251000148, 251000149, Exp. 07/28/2026; 251000156, 251000157, Exp. 08/08/2026; 251000164, 251000165, 251000166, Exp. 08/22/2026; 251000169, Exp. 08/29/2026; 251000171, 251000172, Exp. 09/03/2026; 251000180, Exp. 09/19/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0324-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0324-2026. Report a data issue: hello@regdatalab.com.